期刊
CURRENT OPINION IN CHEMICAL BIOLOGY
卷 32, 期 -, 页码 10-21出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.cbpa.2016.01.009
关键词
-
资金
- Skaggs Institute for Chemical Biology
- National Institutes of Health [DK046335, DK046495]
The list of protein aggregation-associated degenerative diseases is long and growing, while the portfolio of disease modifying strategies is very small. In this review and perspective, we assess what has worked to slow the progression of an aggregation-associated degenerative disease, covering the underlying mechanism of pharmacologic action and what we have learned about the etiology of the transthyretin amyloid diseases and likely amyloidoses in general. Next, we introduce emerging therapies that should apply more generally to protein misfolding and/or aggregation diseases, approaches that rely on adapting the protein homeostasis or proteostasis network for disease amelioration.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据